Anthony Harnesses, Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA), has published the final article in a series of blogs dedicated to the organization's strategy. In the article, he summarized previous publications that addressed issues of innovation, partnerships, and regulatory system development. Harnesses noted that throughout the series, one key theme ran consistently—the importance of listening to stakeholders' views, learning from experience gained, and looking forward to plan further development. According to him, collaboration among various participants in the healthcare system—scientists, physicians, patients, and manufacturers—remains the foundation for the agency's effective work. The MHRA Chairman emphasized that innovation in medicine and pharmaceuticals requires a flexible and modern regulatory approach capable of responding promptly to new technologies and scientific discoveries. He noted that the agency will continue to strengthen partnerships across the UK to ensure timely patient access to safe and effective treatments. In conclusion, Harnesses expressed gratitude to all those who participated in discussing the strategy and noted that feedback from industry specialists and the public helps MHRA improve its work. He added that the agency intends to continue acting transparently and openly, strengthening trust in the drug regulation system in the country.